These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24250305)

  • 21. Similar Weight Loss Induces Greater Improvements in Insulin Sensitivity and Liver Function among Individuals with NAFLD Compared to Individuals without NAFLD.
    Schübel R; Nonnenmacher T; Sookthai D; Gonzalez Maldonado S; Sowah SA; von Stackelberg O; Schlett CL; Grafetstätter M; Nabers D; Johnson T; Kirsten R; Ulrich CM; Kaaks R; Kauczor HU; Kühn T; Nattenmüller J
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30836637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
    Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
    Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
    [No Abstract]   [Full Text] [Related]  

  • 23. Lifestyle interventions for patients with nonalcoholic fatty liver disease: a network meta-analysis.
    Zou TT; Zhang C; Zhou YF; Han YJ; Xiong JJ; Wu XX; Chen YP; Zheng MH
    Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):747-755. PubMed ID: 29683979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients.
    Verrijken A; Francque S; Mertens I; Talloen M; Peiffer F; Van Gaal L
    Int J Obes (Lond); 2010 May; 34(5):899-907. PubMed ID: 20142825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease.
    Bi Y; Min M; Shen W; Deng P; Du Q; Dong M; Liu Y
    Int J Clin Exp Pathol; 2015; 8(7):8494-9. PubMed ID: 26339423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin resistance and metabolic syndrome in patients with NAFLD but without diabetes: effect of a 6 month regime intervention.
    Cankurtaran M; Tayfur O; Yavuz BB; Geyik S; Akhan O; Arslan S
    Acta Gastroenterol Belg; 2007; 70(3):253-9. PubMed ID: 18074733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of endoplasmic reticulum stress, liver function, insulin resistance and vascular endothelial function in patients with nonalcoholic fatty liver disease.
    Zheng Y; Shi H; Zhou Y; Wang A; Kang D; Kang L
    Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(5):210-217. PubMed ID: 35818251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement.
    Dixon JB; Bhathal PS; O'Brien PE
    Obes Surg; 2006 Oct; 16(10):1278-86. PubMed ID: 17059735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is HOMA-IR a potential screening test for non-alcoholic fatty liver disease in adults with type 2 diabetes?
    Gutierrez-Buey G; Núñez-Córdoba JM; Llavero-Valero M; Gargallo J; Salvador J; Escalada J
    Eur J Intern Med; 2017 Jun; 41():74-78. PubMed ID: 28283346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease.
    Mudaliar S; Henry RR; Sanyal AJ; Morrow L; Marschall HU; Kipnes M; Adorini L; Sciacca CI; Clopton P; Castelloe E; Dillon P; Pruzanski M; Shapiro D
    Gastroenterology; 2013 Sep; 145(3):574-82.e1. PubMed ID: 23727264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid hormone levels in obese children and adolescents with non-alcoholic fatty liver disease.
    Torun E; Özgen IT; Gökçe S; Aydın S; Cesur Y
    J Clin Res Pediatr Endocrinol; 2014; 6(1):34-9. PubMed ID: 24637308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Weight-loss-independent benefits of exercise on liver steatosis and stiffness in Japanese men with NAFLD.
    Oh S; Tsujimoto T; Kim B; Uchida F; Suzuki H; Iizumi S; Isobe T; Sakae T; Tanaka K; Shoda J
    JHEP Rep; 2021 Jun; 3(3):100253. PubMed ID: 33898958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Treatment with n-3 Polyunsaturated Fatty Acids as a Monotherapy in Children with Nonalcoholic Fatty Liver Disease.
    Boyraz M; Pirgon Ö; Dündar B; Çekmez F; Hatipoğlu N
    J Clin Res Pediatr Endocrinol; 2015 Jun; 7(2):121-7. PubMed ID: 26316434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Aerobic Exercise Alone or in Conjunction With Diet on Liver Function, Insulin Resistance and Lipids in Non-Alcoholic Fatty Liver Disease.
    Mohammad Rahimi GR; Attarzadeh Hosseini SR
    Biol Res Nurs; 2022 Apr; 24(2):259-276. PubMed ID: 35130757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association between non-alcoholic fatty liver disease and insulin resistance in 20 obese children and adolescents.
    Ciba I; Widhalm K
    Acta Paediatr; 2007 Jan; 96(1):109-12. PubMed ID: 17187615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. INSULIN RESISTANCE AS AN INDICATOR OF DIFFERENTIATION FOR THE FORMATION OF RISK GROUPS FOR NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITHOUT TYPE 2 DIABETES MELLITUS, AS A PART OF ONTOLOGICAL MODEL OF NON-ALCOHOLIC FATTY LIVER DISEASE.
    Nosko NO; Kharchenko VV
    Wiad Lek; 2021; 74(10 cz 2):2593-2598. PubMed ID: 34923463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents.
    de Piano A; de Mello MT; Sanches Pde L; da Silva PL; Campos RM; Carnier J; Corgosinho F; Foschini D; Masquio DL; Tock L; Oyama LM; do Nascimento CM; Tufik S; Dâmaso AR
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1313-24. PubMed ID: 22932160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical significance of insulin resistance in non-diabetic patients with early forms of non-alcoholic fatty liver disease.
    Shipovskaya AA; Dudanova OP; Kurbatova IV
    Ter Arkh; 2018 Aug; 90(8):63-68. PubMed ID: 30701940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a 10-week weight loss camp on fatty liver disease and insulin sensitivity in obese Danish children.
    Grønbæk H; Lange A; Birkebæk NH; Holland-Fischer P; Solvig J; Hørlyck A; Kristensen K; Rittig S; Vilstrup H
    J Pediatr Gastroenterol Nutr; 2012 Feb; 54(2):223-8. PubMed ID: 21760546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.